We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 335 results
  1. Exploring Polypharmacology in Drug Design

    Nowadays it is widely accepted that one compound can be able to hit several targets at once. This “magic shotgun” approach for drug development...
    Patricia Saenz-Méndez, Leif A. Eriksson in Rational Drug Design
    Protocol 2018
  2. An upside-down binding mode to treat psychosis

    Alaina M. Jaster, Javier González-Maeso in Nature Neuroscience
    Article 09 December 2021
  3. Artificial Intelligence and Its Applications in Drug Discovery, Formulation Development, and Healthcare

    Artificial intelligence (AI) is a vast multidisciplinary field which equip machines with cognitive powers like ability to perceive reason, learn,...
    Debadri Banerjee, Deepti Rajput, ... Vikas Anand Saharan in Computer Aided Pharmaceutics and Drug Delivery
    Chapter 2022
  4. Role of Network Pharmacology in Prediction of Mechanism of Neuroprotective Compounds

    Network pharmacology is an emerging pioneering approach in the drug discovery process, which is used to predict the therapeutic mechanism of...
    Saima, S. Latha, ... Anoop Kumar in Neuroprotection
    Protocol 2024
  5. Antiviral Phytocompounds Against Animal-to-Human Transmittable SARS-CoV-2

    Pandemics of lethal coronaviruses have created huge challenges to healthcare systems over the last few years. The fast proliferation of severe acute...
    Chapter 2023
  6. Targeting purinergic receptors to attenuate inflammation of dry eye

    Inflammation is one of the potential factors to cause the damage of ocular surface in dry eye disease (DED). Increasing evidence indicated that...

    Jia-Ning Wang, Hua Fan, Jian-Tao Song in Purinergic Signalling
    Article Open access 26 February 2022
  7. Network-Driven Drug Discovery

    We describe an approach to early stage drug discovery that explicitly engages with the complexities of human biology. The combined computational and...
    Jonny Wray, Alan Whitmore in Artificial Intelligence in Drug Design
    Protocol 2022
  8. Network-Based Target Identification

    Target identification may help to find potential therapeutic or adverse effects for active compounds and further optimize the structures of these...
    Zengrui Wu, Yun Tang in Drug Target Selection and Validation
    Chapter 2022
  9. Meeting the Unmet Challenges of Pharmaceutical Research Using Artificial Intelligence

    Over the last decade, artificial intelligence (AI) has piqued attention in the various areas of robotics, healthcare, E-commerce, and so on. But the...
    Chapter 2023
  10. Pharmacologically significant constituents collectively responsible for anti-sepsis action of XueBi**g, a Chinese herb-based intravenous formulation

    Sepsis, a life-threatening health issue, lacks effective medicine targeting the septic response. In China, treatment combining the intravenous herbal...

    Chen Cheng, Chao Ren, ... Yong-ming Yao in Acta Pharmacologica Sinica
    Article 24 January 2024
  11. Image-based profiling for drug discovery: due for a machine-learning upgrade?

    Image-based profiling is a maturing strategy by which the rich information present in biological images is reduced to a multidimensional profile, a...

    Srinivas Niranj Chandrasekaran, Hugo Ceulemans, ... Anne E. Carpenter in Nature Reviews Drug Discovery
    Article 22 December 2020
  12. Mannose: a potential saccharide candidate in disease management

    There are a plethora of antibiotic resistance cases and humans are marching towards another big survival test of evolution along with drastic climate...

    M. Dhanalakshmi, D. Sruthi, ... Jayashankar Das in Medicinal Chemistry Research
    Article 20 January 2023
  13. Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists

    The paradigm of one drug against multiple targets, known as unimolecular polypharmacology, offers the potential to improve efficacy while overcoming...

    Sanaz Darbalaei, Ru-lue Chang, ... De-hua Yang in Acta Pharmacologica Sinica
    Article 11 August 2022
  14. Kinase drug discovery 20 years after imatinib: progress and future directions

    Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or mutations in their genes, cause cancer and other...

    Philip Cohen, Darren Cross, Pasi A. Jänne in Nature Reviews Drug Discovery
    Article 17 May 2021
  15. The state of the art in secondary pharmacology and its impact on the safety of new medicines

    Secondary pharmacology screening of investigational small-molecule drugs for potentially adverse off-target activities has become standard practice...

    Richard J. Brennan, Stephen Jenkinson, ... Jean-Pierre Valentin in Nature Reviews Drug Discovery
    Article 21 May 2024
  16. Artificial Intelligence in Drug Discovery and Development

    Recently, machine learning (ML) and artificial intelligence (AI) have gained popularity in the healthcare sector. In the field of drug discovery and...
    Geethaa Sahgal, Jeevandran Sundarasekar in Concepts in Pharmaceutical Biotechnology and Drug Development
    Chapter 2024
  17. Application of Artificial Intelligence and Machine Learning in Drug Discovery

    Machine Learning (ML) and Deep Learning (DL) are two subclasses of Artificial Intelligence (AI), that, in this day and age of big data provides...
    Protocol 2022
  18. Gene set enrichment analysis, network pharmacology and in silico docking approach to understand the molecular mechanism of traditional medicines for the treatment of diabetes mellitus

    Herbal constituents, present in most traditional medicines, are known to act on multiple targets and exert therapeutic activities but often lack...

    Vishal S. Patil, Sanjay H. Deshpande, ... Subarna Roy in Journal of Proteins and Proteomics
    Article 07 October 2020
  19. Bionoi: A Voronoi Diagram-Based Representation of Ligand-Binding Sites in Proteins for Machine Learning Applications

    Bionoi is a new software to generate Voronoi representations of ligand-binding sites in proteins for machine learning applications. Unlike many other...
    Joseph Feinstein, Wentao Shi, ... Michal Brylinski in Protein-Ligand Interactions and Drug Design
    Protocol 2021
  20. Potential of Artificial Intelligence to Accelerate Drug Development for Rare Diseases

    The growth in breadth and depth of artificial intelligence (AI) applications has been fast, running hand in hand with the increasing amount of...

    Giulio Napolitano, Canan Has, ... Carsten Ullrich in Pharmaceutical Medicine
    Article 05 February 2024
Did you find what you were looking for? Share feedback.